Skip to main content
. 2021 Sep 12;1248:131481. doi: 10.1016/j.molstruc.2021.131481

Table 2.

The results obtained from docking analysis of COVID-19 main protease with 35 compounds.

No ∆Gbinding (kcal/mol) Electrostatc Energy (kcal/mol) vdW + Hbond + desolv Energy (kcal/mol) Final Intermolecular Energy (kcal/mol) Est. Inhibition Constant, Ki (µM)
1 -6.79 +0.15 -9.33 -9.18 10.46
2 -6.85 -0.14 -9.10 -9.24 9.53
3 -5.42 -0.72 -7.39 -8.10 106.93
4 -5.19 -0.36 -7.81 -8.18 155.8
5 -4.02 -0.28 -5.53 -5.81 1130
6 -4.56 -0.22 -6.72 -6.94 458.11
7 -7.89 -0.31 -8.77 -9.08 1.66
8 -8.11 -0.40 -9.50 -9.90 1.13
9 -8.96 -0.60 -9.85 -10.45 0.27149
10 -8.70 -0.62 -987 -10.49 0.42244
11 -5.58 -0.29 -7.08 -7.37 80.96
12 -5.32 -0.54 -5.97 -6.51 126.82
13 -8.51 -0.42 -9.88 -10.30 0.58149
14 -8.32 -0.33 -9.18 -9.51 0.7948
15 -9.12 -0.75 -9.86 -10.61 0.20594
16 -9.27 -0.80 -10.27 -11.06 0.15927
17 -6.02 -0.30 -7.51 -7.81 38.95
18 -5.74 -0.19 -6.74 -6.93 62.04
19 -9.57 -1.06 -10.29 -11.36 0.09676
20 -4.24 -0.87 -4.57 -5.44 773.82
21 -7.24 -3.81 -5.22 -9.03 4.95
22 -7.23 -0.38 -8.64 -9.02 5
23 -6.94 -0.35 -7.79 -8.14 8.12
24 -7.03 -0.78 -7.75 -8.52 7.03
25 -7.99 -0.80 -8.98 -9.78 1.39
26 -7.10 -0.73 -8.16 -8.89 6.21
27 -5.13 -0.68 -5.54 -6.23 173.36
28 -5.04 -0.69 -6.15 -6.83 200.67
29 -8.16 -0.50 -9.58 -10.08 1.04
30 -8.31 -0.37 -9.59 -9.96 0.8069
31 -8.58 -0.53 -9.70 -10.22 0.51533
32 -9.21 -0.57 -10.01 -10.58 0.17826
33 -5.80 -0.33 -7.12 -7.45 55.66
34 -4.65 -1.19 -4.65 -5.84 392.75
35 -6.76 -0.09 -8.04 -8.13 11.08
Adefovir -4.18 -0.30 -6.27 -6.57 859.90
Foscarnet -3.13 -2.04 -2.28 -4.32 512.5
Tenofovir -4.97 -0.10 -10.24 -10.33 229.18
Sofosbuvir -7.06 -0.50 -10.43 -10.94 6.71
Uprifosbuvir -7.08 -0.14 -10.81 -10.96 6.47
Remdesivir -6.75 -0.37 -11.46 -11.82 11.23